Amy Jo Sterling

Array ( [id] => 6870798 [patent_doc_number] => 20030083488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'DNA encoding orphan SNORF66 receptor' [patent_app_type] => new [patent_app_number] => 10/307736 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6479 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083488.pdf [firstpage_image] =>[orig_patent_app_number] => 10307736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843108 [patent_doc_number] => 20030148455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Apo-2 receptor' [patent_app_type] => new [patent_app_number] => 10/288917 [patent_app_country] => US [patent_app_date] => 2002-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 32108 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148455.pdf [firstpage_image] =>[orig_patent_app_number] => 10288917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 679458 [patent_doc_number] => 07083949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Receptor based antagonists and methods of making and using' [patent_app_type] => utility [patent_app_number] => 10/287035 [patent_app_country] => US [patent_app_date] => 2002-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 198 [patent_figures_cnt] => 199 [patent_no_of_words] => 26052 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/083/07083949.pdf [firstpage_image] =>[orig_patent_app_number] => 10287035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 982200 [patent_doc_number] => 06927044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-09 [patent_title] => 'IL-1 receptor based cytokine traps' [patent_app_type] => utility [patent_app_number] => 10/282162 [patent_app_country] => US [patent_app_date] => 2002-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 174 [patent_figures_cnt] => 189 [patent_no_of_words] => 26233 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/927/06927044.pdf [firstpage_image] =>[orig_patent_app_number] => 10282162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 941208 [patent_doc_number] => 06969599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-29 [patent_title] => 'Nucleic acids encoding tumor necrosis factor receptor TR10' [patent_app_type] => utility [patent_app_number] => 10/280047 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 85052 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/969/06969599.pdf [firstpage_image] =>[orig_patent_app_number] => 10280047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6762177 [patent_doc_number] => 20030125539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'DNA encoding SNORF25 receptor' [patent_app_type] => new [patent_app_number] => 10/278455 [patent_app_country] => US [patent_app_date] => 2002-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 38369 [patent_no_of_claims] => 166 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125539.pdf [firstpage_image] =>[orig_patent_app_number] => 10278455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 809852 [patent_doc_number] => 07416848 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-26 [patent_title] => 'DNA encoding SNORF25 receptor' [patent_app_type] => utility [patent_app_number] => 10/278437 [patent_app_country] => US [patent_app_date] => 2002-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 37768 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/416/07416848.pdf [firstpage_image] =>[orig_patent_app_number] => 10278437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638632 [patent_doc_number] => 20030211967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Method for selectively inhibiting ghrelin action' [patent_app_type] => new [patent_app_number] => 10/258259 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5164 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211967.pdf [firstpage_image] =>[orig_patent_app_number] => 10258259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6971643 [patent_doc_number] => 20050037353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Highly sensitive methods for protein detection in proteomics' [patent_app_type] => utility [patent_app_number] => 10/492860 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5105 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037353.pdf [firstpage_image] =>[orig_patent_app_number] => 10492860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6647167 [patent_doc_number] => 20030104447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses' [patent_app_type] => new [patent_app_number] => 10/269353 [patent_app_country] => US [patent_app_date] => 2002-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 51083 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 268 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104447.pdf [firstpage_image] =>[orig_patent_app_number] => 10269353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846834 [patent_doc_number] => 20030166001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Toll-like receptor 3 signaling agonists and antagonists' [patent_app_type] => new [patent_app_number] => 10/265072 [patent_app_country] => US [patent_app_date] => 2002-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15473 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166001.pdf [firstpage_image] =>[orig_patent_app_number] => 10265072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 506942 [patent_doc_number] => 07198789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-03 [patent_title] => 'Methods and compositions for modulating interleukin-21 receptor activity' [patent_app_type] => utility [patent_app_number] => 10/264634 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 63 [patent_no_of_words] => 38050 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/198/07198789.pdf [firstpage_image] =>[orig_patent_app_number] => 10264634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 958725 [patent_doc_number] => 06953670 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-11 [patent_title] => 'Methods for identifying compounds capable of supplementing the biological activity of leptin' [patent_app_type] => utility [patent_app_number] => 10/245616 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5232 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 266 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/953/06953670.pdf [firstpage_image] =>[orig_patent_app_number] => 10245616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861036 [patent_doc_number] => 20030092044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/243157 [patent_app_country] => US [patent_app_date] => 2002-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 29946 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092044.pdf [firstpage_image] =>[orig_patent_app_number] => 10243157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 749355 [patent_doc_number] => 07022499 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-04 [patent_title] => 'Nucleic acids encoding differentiation inhibitor delta 2' [patent_app_type] => utility [patent_app_number] => 10/241476 [patent_app_country] => US [patent_app_date] => 2002-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17444 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022499.pdf [firstpage_image] =>[orig_patent_app_number] => 10241476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6726470 [patent_doc_number] => 20030208782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Massi gene, a target for anticonvulsant drug development' [patent_app_type] => new [patent_app_number] => 10/220587 [patent_app_country] => US [patent_app_date] => 2002-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9103 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20030208782.pdf [firstpage_image] =>[orig_patent_app_number] => 10220587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658608 [patent_doc_number] => 20030078407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'DNA encoding orphan SNORF53 receptor' [patent_app_type] => new [patent_app_number] => 10/232539 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6501 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078407.pdf [firstpage_image] =>[orig_patent_app_number] => 10232539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 650833 [patent_doc_number] => 07112410 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-26 [patent_title] => 'Human tumor necrosis factor TR21 and methods based thereon' [patent_app_type] => utility [patent_app_number] => 10/229352 [patent_app_country] => US [patent_app_date] => 2002-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 112348 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/112/07112410.pdf [firstpage_image] =>[orig_patent_app_number] => 10229352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6692219 [patent_doc_number] => 20030039651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Use of certain drugs for treating nerve root injury' [patent_app_type] => new [patent_app_number] => 10/225237 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14830 [patent_no_of_claims] => 199 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20030039651.pdf [firstpage_image] =>[orig_patent_app_number] => 10225237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 623499 [patent_doc_number] => 07138276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-21 [patent_title] => 'Differentiation-suppressive polypeptide serrate-2 and methods of use' [patent_app_type] => utility [patent_app_number] => 10/219248 [patent_app_country] => US [patent_app_date] => 2002-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17607 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/138/07138276.pdf [firstpage_image] =>[orig_patent_app_number] => 10219248 [rel_patent_id] =>[rel_patent_doc_number] =>)